Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+745K
-
Total reported value, excl. options
-
$218M
-
Value change
-
+$7.95M
-
Put/Call ratio
-
0.93
-
Number of buys
-
49
-
Number of sells
-
-38
-
Price
-
$10.69
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2018
104 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q2 2018.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 77M outstanding shares and own 26.48% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.37M shares), BlackRock Inc. (1.86M shares), RA CAPITAL MANAGEMENT, LLC (1.53M shares), MILLENNIUM MANAGEMENT LLC (1.25M shares), VANGUARD GROUP INC (1.23M shares), Cormorant Asset Management, LP (1.2M shares), SPHERA FUNDS MANAGEMENT LTD. (1.07M shares), Rock Springs Capital Management LP (975K shares), NORTHPOINTE CAPITAL LLC (816K shares), and PERCEPTIVE ADVISORS LLC (708K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.